Get started
Author

Suming Pan

Observed name: Su-Ming Pan
ORCID: 0000-0003-0005-5602
Observed ORCID: 0000-0003-0005-5602
OpenAlex ID: A5012330399
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
2019 · Yuan Fang, Zhi-Yong Shen, et al. · Nature Communications · 257
PDF
Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy
2014 · Pingpin Wei, Man Niu, et al. · Stem Cell Research & Therapy · 42
PDF
MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma
2016 · Man Niu, Dan Gao, et al. · BMC Cancer · 34
PDF
Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients
2018 · Xiao-Jing Du, Su-Ming Pan, et al. · Frontiers in Oncology · 33
PDF
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review)
2021 · Shan-Qiang Zhang, Su-Ming Pan, et al. · International Journal of Oncology · 30
PDF
Efficacy and Safety of KL-A167 in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Single-Arm, Phase 2 Study
2022 · Yuankai Shi, Xintian Qin, et al. · The Lancet Regional Health - Western Pacific · 29
Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human
2019 · Yao Fan, Longshan Zhang, et al. · Cancer Gene Therapy · 25
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
2021 · Mi Yang, Xixi Wu, et al. · Clinical and Translational Medicine · 23
PDF
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
2026 · Fei Han, Xing Lv, et al. · Med · 13
Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma
2022 · Shan-Qiang Zhang, Su-Ming Pan, et al. · Frontiers in Oncology · 4
PDF
Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine
2021 · Sixian Liang, Yin Li, et al. · Anti-Cancer Agents in Medicinal Chemistry · 4
A multicenter, randomized, double-blind study of gefitinib in combination with anlotinib or placebo in previously untreated patients with EGFR mutation-positive advanced non-small cell lung cancer (FL-ALTER).
2021 · Li Zhang, Wenfeng Fang, et al. · Journal of Clinical Oncology · 3
Inflammation-Related Biomarker COMMD10 Values Up BCLC Staging in Individualized Prediction of Overall Survival in Hepatocellular Carcinoma
2019 · Mi Yang, XiXi Wu, et al. · SSRN Electronic Journal
Works count: 13
Citation count: 497
H-index: 9
I10-index: 9
Year
Topic
Type